Obtaining tissue diagnosis in lung cancer patients with poor performance status and its influence on treatment and survival.

INTRODUCTION 25% of patients with lung cancer have performance status 3 or 4. A pragmatic approach to investigative procedures is often adopted based on the risks and benefits in these patients and whether tissue diagnosis is necessary for anticipated future treatment. This cohort study investigated factors influencing a clinician's decision to pursue a… CONTINUE READING